RS1 rs387906258: Understanding the Genetic Basis of XLRS
The rs387906258 variant is a specific genetic change within the RS1 gene that alters the retinoschisin protein. This variant is associated with X-linked juvenile retinoschisis, a condition characterized by the splitting of retinal layers and progressive vision loss.
What each genotype means
Typical retinoschisin function
This genotype represents the common, functional version of the RS1 gene. Individuals with this genotype produce the retinoschisin protein as expected, which is necessary for maintaining the structural integrity of the retina.
This is the most common genotype found in the general population.
Carrier of RS1 variant
This genotype indicates you carry one copy of the p.Glu72Lys variant on one of your X chromosomes. Because this condition is X-linked, female carriers typically do not exhibit the symptoms of juvenile X-linked retinoschisis, though they should discuss family planning and genetic counseling with a specialist.
This genotype is extremely rare and is primarily identified in female relatives of affected male probands.
Associated with juvenile retinoschisis
This genotype indicates the presence of the p.Glu72Lys variant in the RS1 gene, which is associated with juvenile X-linked retinoschisis. This condition involves the splitting of retinal layers and progressive vision loss, and individuals with this result should consult with an ophthalmologist or clinical geneticist for evaluation and management.
This genotype is extremely rare in the general population and is recurrently identified in male patients diagnosed with juvenile X-linked retinoschisis.
What is the rs387906258 Variant?
The variant rs387906258 is a missense substitution located within the RS1 gene. In this specific change, the amino acid glutamic acid is replaced by lysine at position 72 (p.Glu72Lys). Because the RS1 gene is located on the X chromosome, this variant follows an X-linked inheritance pattern. This means that males, who have only one X chromosome, are primarily affected if they carry the variant, as they lack a second, functional copy of the gene to compensate for the change. The variant is categorized as a trait-associated change, specifically linked to the disruption of the discoidin domain, which is a critical functional component of the retinoschisin protein. Understanding this variant requires looking at how it alters the protein's ability to maintain the structural integrity of the retina.
The Role of the RS1 Gene
The RS1 gene provides the essential instructions for producing a protein called retinoschisin. This protein is secreted by photoreceptor and bipolar cells in the retina, the light-sensitive tissue at the back of the eye. Retinoschisin acts as a structural "glue" that helps organize the layers of the retina and maintains the synaptic connections between cells. It functions as a homo-oligomeric complex, meaning multiple copies of the protein assemble into a larger structure to perform its work. When the RS1 gene is functioning normally, it ensures that the retina remains properly stratified and that light signals are effectively relayed from the eye to the brain. Mutations in this gene, such as the one described by rs387906258, can impair the protein's folding, secretion, or its ability to bind to cell surfaces, leading to the structural instability characteristic of retinal disease.
Research and Clinical Associations
Research into rs387906258 is primarily focused on its role in X-linked juvenile retinoschisis (XLRS). This condition is a form of early-onset macular degeneration that causes the inner layers of the retina to split, or 'schisis,' leading to significant vision loss. The evidence linking this specific variant to the condition is considered limited but clinically significant, as it has been recurrently identified in male patients presenting with the symptoms of XLRS. Studies suggest that the p.Glu72Lys substitution disrupts the discoidin domain, which is vital for the protein's function in cell adhesion. While the association is well-documented in clinical case reports of affected families, the overall strength of evidence remains categorized as limited in broader genomic databases. It is important to note that this information is for educational purposes and does not constitute a medical diagnosis or prognosis.
Population Frequency and Distribution
The population frequency of the rs387906258 variant is extremely low, as indicated by large-scale genomic databases like gnomAD. The hemizygote count—representing males who carry the variant on their single X chromosome—is very small. Because the condition is rare and the variant is typically identified through clinical testing of symptomatic individuals rather than general population screening, it is not considered a common polymorphism. The variant is primarily observed in male probands who have been clinically diagnosed with juvenile retinoschisis. Due to its rarity, there is limited data on its distribution across different global ancestries. The presence of this variant is generally restricted to families with a history of the condition, highlighting its nature as a rare, pathogenic-associated variant rather than a common genetic marker found in the general population.
Navigating Genetic Information
If you or a family member have received information regarding the rs387906258 variant, it is essential to understand what this means in a clinical context. Genetic variants in the RS1 gene are associated with specific inherited retinal conditions, and this information should be discussed with a qualified healthcare provider, such as a genetic counselor or an ophthalmologist specializing in retinal diseases. You cannot 'treat' or 'change' this variant through lifestyle choices, and it is not a marker for a common, preventable trait. Instead, this information is used by clinicians to confirm a diagnosis or to provide context for family planning and genetic counseling. Always rely on professional medical advice for interpreting genetic test results, as they can provide the necessary context regarding your specific health history and the implications for your family.
How common is this variant?
The rs387906258 variant is extremely rare in the general population, with a very low hemizygote count in gnomAD, and is primarily identified in clinical settings among male probands.
Frequently asked questions
What is X-linked juvenile retinoschisis?
X-linked juvenile retinoschisis is a genetic eye disorder that causes the splitting of the retinal layers. It typically affects males and leads to progressive vision loss starting in childhood.
Can I be tested for the rs387906258 variant?
Yes, this variant can be identified through clinical genetic testing. You should consult with an ophthalmologist or a genetic counselor to determine if testing is appropriate for your situation.
Is there a cure for conditions caused by RS1 mutations?
Currently, there is no cure for X-linked juvenile retinoschisis. Management focuses on monitoring vision and addressing complications, and you should discuss potential clinical trials or supportive care with your eye specialist.
Why is this variant only found in males?
The RS1 gene is located on the X chromosome. Males have only one X chromosome, so if they inherit a variant, they do not have a second copy to provide a functional protein, which is why they are more likely to be affected.
Sources & further reading
Educational information only, last refreshed 9/19/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs387906258?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in RS1
Pathogenic missense variant disrupting the discoidin domain of retinoschisin, causing X-linked juvenile retinoschisis.
Encodes the Arg102Gln missense variant in retinoschisin, causing X-linked juvenile retinoschisis with macular splitting and reduced central vision.
An X-linked missense variant in retinoschisin leading to X-linked juvenile retinoschisis and early macular splitting.
Pathogenic splice/missense variant in RS1 implicated in X-linked juvenile retinoschisis with characteristic macular splitting and decreased visual acuity.
An X-linked missense substitution in retinoschisin leading to progressive foveal splitting and early-onset juvenile retinoschisis.